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1. Introduction 
Melanoma, an aggressive tumor of the melanocytes is more prevalent among the  
white-skinned individuals with the highest incidence reported from Australia and New 
Zealand (Elwood M,2002). Primary melanomas usually involve the skin, mucosa, retina and 
leptomeninges. They are known to metastasize to lymph nodes, lung, liver and virtually any 
part of the body (Basler et al., 1997; Saqi et al., 2002; Ustün et al., 2002; De Las Casas et al., 
2004; Parwani et al., 2004; Mohr et al., 2009). Surgical excision with adequate margins is the 
treatment of choice for cutaneous melanoma. The prognosis of melanoma varies with the 
site and stage of the disease (Damala et al., 2004; Mohr et al., 2009). Advanced disease with 
local recurrence, or distant metastasis carries a grave prognosis (Saqi et al., 2004). A variety 
of imaging techniques such as the chest and abdominal computed tomography (CT) scan, 
magnetic resonance imaging (MRI) of the brain and positron emission tomography (PET) 
are used in the staging work-up of patients with cutaneous melanoma, chiefly, for 
evaluating the potential metastatic sites such as the lungs, lymph nodes, liver and brain. An 
imaging work-up is generally not recommended in patients with a <1.0 mm thick lesion, as 
the cure rate in such cases is >90%. It is also not essential in patients with primary 
melanoma thicker than 1.0 mm, wherein a sentinel lymph node biopsy (SLNB) serves as a 
better staging tool (Mohr et al., 2009).  
Justifiably, histologic examination of the surgical biopsies plays a major role in the diagnosis 
of primary and metastatic melanomas. Nonetheless, role of non-invasive/  minimally 
invasive cytologic techniques has also been adequately addressed (Rai, 2007). The cytologic 
techniques vary with the nature and location of the lesion and these include fine needle 
aspiration cytology (FNAC), imprint cytology (IC), scrape cytology, as well as, the 
examination of exfoliative samples such as the serous body fluids, sputum, cerebrospinal 
fluid (CSF) and synovial fluid (Paridaens et al., 1992; Deshpande et al., 2001; Saqi et al., 2002; 
Ali et al., 2005). Of these, FNAC is widely employed and its primary role is to confirm the 
metastatic or recurrent melanoma lesions (Saqi et al., 2002; Mágori, 2003; Siddaraju et al., 
2007). By cytologic means, various authors have been able to detect metastatic melanoma 
deposits in a wide variety of sites inclusive of adrenal, kidney, omentum, pancreas, parotid, 
soft tissue, spine, breast, thyroid and brain (Saqi et al., 2002; Artal et al., 2004; Hernandez et 
al., 2004; Gombos et al., 2004; Bozbora et al., 2005; Kung et al., 2009; Kaneko et al., 2009). Not 
infrequently, cytology is used for diagnosing primary melanoma as well (Layfield et al., 
1993; Dey et al., 1996; Gupta et al., 2003; Mágori, 2003; Kotoulas et al., 2007). A significant 
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literature is also available with regard to the cytologic diagnosis of ocular melanomas 
(Paridaens et al., 1992; Kashyap et al., 2002; Augsburger et al., 2002; Char et al., 2006; Young 
et al., 2007, 2008; Solo et al., 2009). Ultrasound (US) or computed tomography (CT) guided 
FNAC is particularly valuable for visceral metastases. More recently, lymph node 
ultrasound (US) with fine needle aspiration cytology (FNAC) is considered a potential cost 
effective alternative for an SLNB (Voit et al., 2006; van Akkooi et al., 2010). Although, rare 
studies have reported very low sensitivity which is attributed to tiny and necrotic lesions 
(Voit et al., 1999; van Rijk et al., 2006); most authors have emphasized the importance of US-
guided FNAC in the detection of sentinel lymph node metastasis (Voit et al., 1999, 2002, 
2006 & 2010). With a positive cytology of the sentinel node, surgeons can proceed with the 
direct radical lymph node dissection in patients with melanoma. Significantly, attempts 
have also been made to apply molecular- based techniques on the material obtained by 
FNA, as well as on exfoliative samples (Angeletti et al., 2004; Kalogeraki 2006; Maat et al., 
2007; Savoia et al., 2008; McCannel et al., 2010).  
The present chapter deals chiefly with the role of cytology in the clinical management of 
melanoma patients. A careful evaluation of cytologic samples is of critical importance for a 
variety of reasons, going to be addressed subsequently in this chapter. Despite the 
considerable, current knowledge about the cytomorphology of melanoma, owing to its 
inherent histomorphologic variation; a cytologic diagnosis is often difficult, especially, when 
the lesions are encountered in unusual locations, or with amelanotic presentation. 
Apparently, such situations necessitate the need for ancillary tests like 
immunocytochemistry (ICC) and ultrastructural examination (Mágori, 2003; Rosai, 2005). 
The importance of clinical history need not be overemphasized when interpreting cytologic 
specimens; for example, a known history of melanoma can significantly contribute to a 
cytodiagnosis of recurrent and metastatic melanoma (Mágori, 2003). 
2. Histopathology of melanoma  
Melanoma is well-known for its widely varied histomorphologic pattern. The major 
histologic forms include superficial spreading melanoma, nodular melanoma, acral 
lentigenous melanoma and desmoplastic melanoma (Piris et al., 2010). The histologic 
patterns include pseudo-glandular, pseudo-papillary, peritheliomatous, hemangiopericytoma-
like, trabecular and alveolar. The tumor may be associated with fibroblastic response, 
formation of metaplastic or neoplastic cartilage, osteoclast-like giant cells and pseudo-
epitheliomatous hyperplasia of the overlying dermis (Rosai, 2005). Also described are the 
cases of psammomatous, myxoid, balloon cell and signet ring cell melanomas (Eckert et al., 
1992; Mowat et al., 1994; Hitchcock et al., 1999; Monteagudo et al., 2001). Individual 
melanoma cells can be epithelioid, spindle shaped or extremely bizarre with their size 
ranging from that of a small lymphocyte to giant multinucleate forms. The cytoplasm may 
be eosinophilic, basophilic, foamy, rhabdoid, oncocytic, or completely clear. Melanin can be 
abundant or absent (amelanotic). Malignant melanoma is readily diagnosed by the presence 
of melanin granules. Although amelanotic melanoma can also contain a few melanin 
granules, it is often difficult to differentiate it from non-melanotic tumors (Rosai, 2005). 
Currently, the criteria considered for the histologic diagnosis of cutaneous melanoma 
include the asymmetry and poor circumscription of the lesion; predominance of single 
melanocytes; irregular confluent nests; suprabasal melanocytes; hair follicle involvement 
and absence of maturation; cytologic atypia; dermal lymphocytic infiltrate and necrosis. 
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However, the diagnostic process should not just involve the mechanical use of these 
histologic parameters; as a study by Urso et al. has clearly established that, one or more of 
these histologic features are often present in benign melanocytic nevi as well. Of these, 
absence of maturation, mitoses and necrosis are never encountered in benign nevi (Urso et 
al., 2005). The versatile histologic patterns and responses of melanoma are apparently 
reflected on the cytologic materials as well.  
3. Cytologic evaluation of melanoma 
3.1 Technical aspects 
The most commonly used cytologic technique is the fine needle aspiration (FNA); however, 
exfoliative and imprint cytology are also used depending on the clinical situation (Paridaens 
et al., 1992; Deshpande et al., 2001; Saqi et al., 2002). The technique of FNAC is as per that 
described in any of the standard text books (Orell & Vielh, 1999). Orbital FNA is performed 
via transcleral, transcorneal or transvitreal approach using 25-30guage needle (Augsburger 
et al., 2002; Char et al., 2006; Young et al., 2007, 2008). For tiny and vascular lesions,  
non-aspiration technique is preferable (Solo et al., 2009). In case of suspected conjunctival 
melanoma, imprint cytology using cellulose acetate strips has been found to be very useful 
(Paridaens et al., 1992). Imprint cytology of sentinel node can give a quicker and reliable 
result (Badgwell et al., 2011). Touch imprints taken from the edge of the primary cutaneous/  
mucosal ulcerative lesion can often assist in distinguishing a carcinoma from melanoma. 
Figure 1 is that of a touch imprint taken from the ulcer edge in one of our cases of melanoma. 
 
 
Fig. 1. An imprint taken from the ulcer edge showing pigmented cells; a few characteristic 
extracellular melanin granules are also appreciated (MGG stain, X400) 
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3.2 Naked eye examination of cytologic samples 
Gross nature of the cytologic material in cases of pigmented melanoma is usually blackish 
and often fluid-like (Artal et al., 2004). With respect to melanotic melanomas, this is our 
experience as well. Rare cases of metastatic melanoma manifesting with blackish pleural 
effusion have been documented. Naked eye examination of such fluid material should serve 
as a ‘clue’ to the metastatic involvement of the thorax by melanoma. However, clinicians, as 
well as, the pathologists should be aware of the fact that a blackish effusion is often related 
to bacterial and fungal infections, or to hemorrhage (Liao et al., 2010).  
3.3 Microscopic examination of cytologic samples 
As for the microscopic picture, irrespective of primary, recurrent, metastatic, melanotic or 
amelanotic melanomas; a striking cytomorphologic feature documented by most authors is 
its high cell-yield with a predominant population of dissociated cells (Woyke et al., 1980; 
Perry et al., 1986; Nasiell et al., 1991 Deshpande et al., 2001; Saqi et al., 2002; De Las Casas et 
al., 2004; Parwani et al., 2004; Damala et al., 2004; Siddaraju et al., 2007). Marked cellularity 
and nuclear pleomorphism; with plasmacytoid (cells with eccentrically placed nuclei), 
polygonal or spindle cells; inclusion-like prominent nucleoli; intra-nuclear cytoplasmic 
inclusions; increased mitotic activity; and variable number of bi- and multinucleated cells 
are the other features frequently observed in melanoma (Woyke et al., 1980; Perry et al., 
1986; Kapila et al., 1991; Layfield et al., 1993; Dey et al., 1996; Deshpande et al., 2001; Saqi et 
al., 2002; Kashyap et al., 2002; Gupta et al., 2003; Artal et al., 2004; Gombos et al., 2004; 
Siddaraju et al., 2007). Melanotic melanomas show a variable amount of pigment. Even the 
cases of amelanotic melanomas often exhibit coarse or fine pigment granules in rare or, a 
few cells which can be picked up on careful cytologic examination (Perry et al., 1986; Kapila 
et al., 1991; Deshpande et al., 2001). The cytologic diagnosis of amelanotic melanoma is 
challenging; because, in the absence of pigment, the tumor cells may mimic those of 
carcinoma or sarcoma in cytologic samples, particularly those obtained by fine needle 
aspiration. Irregular nuclear outline and coarse chromatin are the features common to any of 
the malignant lesions, which is also applicable for melanoma cells (Woyke et al., 1980; 
Layfileld et al., 1993; Deshpande et al., 2001).  
Of the general cytomorphologic features elaborated above, intranuclear cytoplasmic 
inclusions (INCIs) are of diagnostic importance, only in conjunction with other 
cytomorphologic and clinical features. Their occurrence in papillary (PTC), medullary 
(MTC) and anaplastic thyroid carcinomas (ATC); bronchioloalveolar carcinoma (BAC), 
hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC) is well known (Orell, 
Silverman, Leiman, 1999). Interestingly, we have also documented a rare case of 
embryonal rhabdomyosarcoma manifesting with frequent INCIs on FNAC (Kumar et al., 
2009). Often, we have observed them as artifactual change in the cervicovaginal smears 
(perhaps due to air drying artefact) and in degenerated cells on FNAC. Uncommonly, 
they have also been noticed in certain benign lesions such as pigmented villonodular 
synovitis and inflammatory psedotumors (Gangane et al., 2003; Hosler et al., 2004). The 
table1 highlights some of the common, as well as, rare conditions that manifest with 
INCIs along with the clinical and cytologic features that assist in their distinction from 
each other. This aspect is of importance, particularly, while dealing with the metastatic 
lesions. 
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Serial 
no. 
Condition Incidence  Major cytologic / clinical features 
assisting in accurate diagnosis 
1 Melanoma  Frequent High cell-yield, dissociated 
pleomorphic cells, melanin pigment, 
inclusion-like nucleoli, intranuclear 
cytoplasmic inclusions (INCIs), 
expression of melanoma markers 
2 Papillary thyroid 
carcinoma (PTC) 
Frequent  Papillary pattern, metaplastic 
epithelial cells, nuclear grooves and 
other associated features 
3 Medullary thyroid 
carcinoma (MTC) 
Less frequent 
than PTC 
Amyloid, cytoplasmic red granules 
4 Anaplastic thyroid 
carcinoma (ATC) 
Less frequent 
than PTC 
Rapid clinical course, absent 
expression of melanoma markers 
5 Bronchioloalveolar 
carcinoma (BAC) 
Common  Prominent clustering, papillary and 
adeno pattern 
6 Hepatocellular 
carcinoma (HCC) 
Common  Sinusoidal pattern, cords of cells, 
naked nuclei, intracellular bile 
pigment (well differentiated), 
Elevated serum alpha-feto protein 
(AFP) 
7 Renal cell carcinoma 
(RCC) 
Common  Single cells, cohesive fragments, 
sheet-like pattern, finely 
vacuolated/ granular cytoplasm, 
bland nuclei in low grade RCC 
8 Embryonal 
rhabdomyosarcoma 
(ERMS) 
Extremely  
unusual 
Small round cell tumor, strap cells, 
expression of muscle markers 
9 Artifactual  
(our unpublished 
observation) 
Due to  
processing 
defect or 
degenerative 
change 
Poor quality smears 
Benign lesions 
1 Inflammatory 
pseudotumor (Hosler 
et al., 2004) 
Uncommon Prominent inflammatory component, 
features identifiable as reactive 
changes 
2 Pigmented villonodular 
synovitis (Gangane et 
al., 2003) 
Uncommon  Joint involvement, demonstration of 
hemosiderin pigment by Perl’s stain 
3 Epithelioid 
angiomyolipoma (orell, 
1999) 
Well known Associated adipocyte component 
Table 1. Showing differential diagnosis of intranuclear cytoplasmic inclusions (INCIs) 
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Fig. 2. Our case of recurrent amelanotic melanoma showing plasmacytoid cells; inset 
highlights distinct INCIs (MGG stain, X400) 
 
 
Fig. 3. Another microscopic field from the same case showing multinucleated giant cells 
with a mitosis (MGG stain, X400); inset shows a digitally magnified cell with an ecto-
endocytoplasmic differentiation and prominent inclusion-like nucleoli (PAP stain, x400) 
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Reviewing further literature on cytology of melanoma is perhaps; of immense help to the 
clinicians in understanding the diagnostic difficulties encountered, especially by the 
cytopathologists. In fact, there is a genuine need for the close interaction between the 
clinicians and pathologists for the proper management of patients with melanoma. Naseill 
et al. (1991) categorized 81 metastatic melanomas on cytology into classic, carcinoma-like, 
spindle cell, lymphoma-like, myxoid, clear cell and undifferentiated melanomas. This 
clearly explains why melanoma has a varied differential diagnosis consisting of a variety of 
carcinomas, sarcomas and hematolymphoid malignancies that often comprise also of non-
Hodgkin’s lymphoma (NHL) (Naseill et al., 1991) and plasmacytoma/  myeloma (Siddaraju 
et al., 2007). In this context, we like to share one of our interesting cases of a recurrent 
melanoma that manifested with 3 different swellings (axilla, chest wall and back) exhibiting 
features of a pleomorphic malignant tumor on FNAC. At presentation, the patient’s 
requisition carried a diagnosis of recurrent soft tissue sarcoma, with which the cytologic 
findings did not match. Cytomorphology varied so widely, with most of the cells displaying 
plasmacytoid appearance (figure 2). At one stage, owing to the elderly age of the patient, we 
had a suspicion of plasmacytoma/  myeloma, although, cytologic and clinical features were 
not very typical. Numerous bizarre bi-nucleate and multi-nucleate giant cells (figure 3); 
variable chromatin pattern; prominent inclusion-like nucleoli; frequent intra-nuclear 
cytoplasmic inclusions (figure 2: inset); varied cytoplasmic features (figure 4) such as 
intensely eosinophilic, as well as, basophilic cytoplasm; cytoplasmic vacuolations; rare 
signet ring cells and cells with ecto-endoplasmic differentiation (figure 3: inset) were noted. 
There were also a few strands of fibrocollagenous tissue, to which the tumor cells were 
adherent (figure 4: inset); this corresponded with the distinct alveolar pattern observed on 
the later review of the histologic sections. Some of the cytologic features suggested an  
 
 
Fig. 4. A smear showing cells with varied cytoplasmic features; inset shows a fibrocollagenous 
strand with adherent neoplastic cells (PAP stain, x400)  
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amelanotic melanoma; however, in view of the clinical diagnosis of recurrent soft tissue 
sarcoma, we offered a diagnosis of an undifferentiated malignant tumor with a possibility of 
amelanotic melanoma. Subsequently, we learnt that it was diagnosed elsewhere, as a 
malignant peripheral nerve sheath tumor (MPNST), based on its immunoexpression of  
S-100. Histologically, the sections revealed a prominent alveolar pattern, vaguely simulating 
an alveolar rhabdomyosarcoma with a tiny focus displaying junctional activity. We 
procured the paraffin tissue blocks of this case and performed IHC with desmin, S100, and 
Melan-A, of which the latter two markers were strongly positive (figures 5&6), confirming 
our cytologic suspicion of melanoma (Siddaraju et al., 2007). 
Other unusual cytologic features described by the various authors are the papillary 
fragments with fibrovascular cores (Baloch et al., 1999), myxoid stroma (Elliot et al., 2001) 
ballon cells (Friedman et al., 1982), signet ring cells (Siddaraju et al., 2007) with 
pseudolipoblastic appearance (Holck et al., 2002), cells with rhabdoid features (Slagel et al., 
1997) and cells arranged in alveolar pattern (Gupta et al., 2003). Although rare, a divergent 
differentiation such as chondroid, neural, myofibroblastic, and osteocartilagenous 
differentiation is well known in melanomas; and the lack of awareness of this fact can create 
serious diagnostic problems to the evaluator. Such an instance is well exemplified by a rare 
case of anal melanoma that also manifested with a mass in the groin. The FNA of the groin 
mass in that particular case revealed a neoplasm rich in chondroid matrix, raising the 
possibility of a second primary mesenchymal tumor. However, a review of the histologic 
slides from the primary growth showed divergent chondroid differentiation in the anal 
melanoma, establishing the metastatic nature of the groin mass (Hanley et al., 2009). Some of 
the variants of melanoma are discussed separately. 
 
 
Fig. 5. Melanoma cells exhibiting cytoplasmic and nuclear expression of S-100 on histologic 
section (IHC stain, X400) 
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Fig. 6. Neoplastic cells with cytoplasmic Melan-A expression on histologic section (IHC 
stain, X400)  
3.3.1 Spindle cell melanoma 
Spindle cell melanoma is a morphologic variant of melanoma which is difficult to diagnose 
on specimens obtained by fine-needle aspiration (FNA). Piao et al. (2008) studied a large 
series (67 patients) of metastatic spindle cell melanomas on FNAC (all primaries were 
histologically proven). The smears were cellular and comprised predominantly of spindle 
cells that frequently formed cohesive fascicles, or whorls intermingled with scattered 
epithelioid tumor cells. Significantly, the common features of melanoma such as dishesive 
cellular distribution, cytoplasmic melanin pigment, intranuclear cytoplasmic inclusions, 
macronucleoli, and binucleation or multinucleation were infrequent in these cases. When 
present, they were found in cells with epithelioid morphology. Remarkably, 9% of the cases 
totally lacked the classic characteristics of melanoma. Spindle cells displayed variable 
cytologic atypia that ranged from deceptively bland cells resembling the reactive fibroblasts 
to those indistinguishable from pleomorphic high-grade sarcomas. When the morphologic 
features were compared with those of the primary tumor, the discrepant cell type was 
observed in 20% of the cases with the previous primary lesions displaying the epithelioid 
morphology. Interestingly, the spindle cells also tended to lose immunoexpression of 
melanoma markers. In such cases, familiarity with cytologic features combined with clinical 
and immunoperoxidase findings are required to avoid misinterpretation (Piao et al., 2008). 
Prominent inclusion-like nucleoli are highly characteristic of melanomas; however, we have 
seen rare cases of pure spindle cell melanoma metastasizing to inguinal nodes that almost 
completely lacked nucleoli. The classic clinical history of pigmented lesion in the sole of 
foot, with cells exhibiting melanin pigment facilitated an easy diagnosis in such instances. 
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On FNAC, in the absence of a reliable clinical history, an amelanotic spindle cell melanoma 
is likely to be mistaken for spindle cell sarcomas, or, in a location like inguinal region, for a 
metastatic squamous cell carcinoma with spindle cell morphology. 
3.3.2 Desmoplastic melanoma 
Desmoplastic melanoma (DM) is an unusual, non-pigmented, sclerosing variant of spindle 
cell malignant melanoma that can range in appearance from sarcomatoid to scar-like lesion. 
Cytomorphologic features described on FNA include a moderate cellularity with pleomorphic 
spindle cells occurring singly and in small aggregates. The spindle cells exhibit plump 
nuclei with deep grooves and folds, coarse and clumped chromatin, and inconspicuous to 
multiple, prominent nucleoli, along with naked spindly nuclei. Intranuclear cytoplasmic 
inclusions are rare. Generally, cytoplasm is scanty to moderate in amount with a fine wispy 
character, clinging to the nuclear poles. Often, a variable amount of dense stromal material 
associated with a few spindle cells is seen. Point to be remembered is that 
immunohistochemically, most desmoplastic melanomas are positive for S-100 and negative 
for specific melanoma markers (van Ells et al., 2007).  
3.3.3 Balloon cell melanoma 
Balloon cell melanoma is a histologic variant composed predominantly, or entirely of large 
cells with abundant, vacuolated cytoplasm. It shares the common cytologic features of 
melanoma, such as discohesion, nuclear pleomorphism and intranuclear cytoplasmic 
pseudoinclusions, but generally lacks melanin pigment; however, it is positive for S-100, 
HMB-45 and Melan-A (Baehner et al., 2005). The entity needs to be distinguished from 
metastatic adenocarcinoma, liposarcoma and other clear cell tumors. 
3.3.4 Signet ring cell melanoma  
Although rare, cytology of signet ring cell melanoma has been on record. Tsang et al. 
(1993) documented a case that manifested as a groin mass in a patient who had undergone 
below knee amputation for superficial spreading melanoma of the right foot. FNA smears 
in this case showed poorly cohesive, large cells with eccentric nuclei, most of which 
exhibited signet ring morphology. Only a small proportion of cells displayed melanin 
pigment clinching the right diagnosis. In the absence of melanin pigment and the clinical 
history, such cases are likely to be misdiagnosed as metastatic signet ring cell 
adenocarcinoma.  Appropriate history and application of ICC can avoid misinterpretation 
of such cases. The case reported by Tsang et al was histologically proven to be a 
‘metastatic signet ring cell melanoma’ with positive expression of HMB-45 and S-100, and 
negativity for cytokeratin. 
3.3.5 Myxoid melanoma 
Myxoid melanoma is an extremely rare variant with only a limited number of cases 
documented. Initial FNA cytologic description of this distinct variant of melanoma was 
given by Rocomora et al. in 1988. The lesion needs to be distinguished from other myxoid 
tumors such as myxoid liposarcoma (myxoid LPS), extraskeletal myxoid chondrosarcoma 
(extraskeletal MCS), myxoid malignant fibrous histiocytoma (myxoid MFH), chordoma and 
malignant peripheral nerve sheath tumor (MPNST). Although certain cytomorphologic 
features assist distinguishing these lesions from each other, a cytopathologist may have to 
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depend on ICC in difficult situations. The table 2 shows the salient clinical, cytologic and 
immunocytochemical features that help distinguishing these lesions. It’s worth noting that 
myxoid melanoma is usually HMB-45 negative, but strongly positive for S-100, along with a 
positive melanoma marker like NK1/ C3 (Elliot et al., 2001). 
 
Tumor  Average age 
(yrs) 
Commonest site Salient cytology  ICC 
Myxoid LPS 46 Deep seated  
tissues- thigh, 
buttock,  
extremities 
Round to spindle cells 
with lipoblasts and 
chicken-wire capillary 
network; lacy myxoid 
background 
S-100 + 
Vimentin + 
Keratin – 
HMB45 – 
Extra skeletal 
MCS 
65 Deep seated  
soft tissue  
of extremities 
Small, round to oval 
cells, pleomorphic 
mesenchymal cells in 
an abundant loose 
myxoid stroma 
S-100 + 
Vimentin + 
Keratin + 
HMB45 – 
Myxoid MFH 65 Thigh, trunk,  
head and neck 
Large, pleomorphic, 
bizarre cells in a 
myxoid background 
S-100 + 
Vimentin + 
Keratin + 
HMB45 – 
Chordoma  Any age for  
spheno-palatine 
site 
Sacrococcygeal, 
spheno-palatine 
Small round to oval 
cells and and 
physaliphorous cells in 
a loose myxoid stroma 
S-100 + 
Vimentin + 
Keratin + 
EMA + 
HMB45 – 
MPNST 3-35  Epithelioid variant: 
large pleomorphic 
cells, INCI +/ -, 
melanin +/ -  
S-100+ 
(focal) 
Vimentin + 
Keratin – 
Desmin – 
HMB45 +/ – 
Table 2. Cytologic differential diagnosis of myxoid melanoma 
3.4 Location-based cytologic interpretation of melanoma 
Differential diagnosis of melanoma depends not only on the overlapping cytomorphologic 
features or patterns, but also on the site of primary or metastatic involvement. For example, 
an amelanotic melanoma of the cervix may have a differential diagnosis of 
rhabdomyosarcoma, mixed malignant mullerian tumor (MMMT), adenocarcinoma and 
poorly differentiated squamous cell carcinoma (Deshpande et al., 2001). An amelanotic 
melanoma (epithelioid type) involving the glandular organs like salivary gland and breast is 
likely to be misinterpreted as an adenocarcinoma (Cangiarella et al., 1998; Bangerter, 2009). 
Similarly, a primary or metastatic spindle cell (amelanotic) melanoma of the breast may 
have a differential diagnosis of a variety of sarcomas such as leiomyosarcoma, malignant 
fibrous histiocytoma (MFH), neurogenic sarcoma, or dermatofibrosarcoma protuberans 
(DFSP) (Artal et al., 2004) and also a malignant phylloides, when epithelial component is 
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absent. There also has been a rare case report of mediastinal spindle cell melanoma which 
was misinterpreted as ‘spindle cell thymoma’ owing to its location in the anterior 
mediastinum. Cytologic smears of this case were hemorrhaghic with a loosely dispersed 
population of spindle cells having prominent nucleoli. A rare situation as this, stresses the 
need for cytopathologists to be cautious when interpreting mediastinal spindle cell lesions. 
Melanoma in the mediastinum is extremely rare and both physicians and pathologists 
should be aware of this remote possibility (Bavi et al. 2005). 
With the fact that melanoma can mimic a wide variety of neoplasms, one also needs to be 
careful while dealing with the aspirates from multiple sites; particularly, in the absence of a 
reliable history, as it is not infrequent to find a coexisting second lesion with melanoma. In 
this context, we share the experience of one of our recent cases with a previous history of 
melanoma of foot. This patient presented with inguinal lymphadenopathy, as well as, an 
intra-abdominal mass. FNA from the inguinal node yielded blackish material, which on 
microscopic examination showed abundant melanin pigment that obscured the morphology 
of neoplastic cells (figure 7); while, the aspirate from the abdominal mass showed well 
preserved cellular elements, with loosely clustered and dissociated population of 
pleomorphic malignant cells (figure 8). Although, variation in cytomorphology of the two 
different aspirates raised suspicion of a dual malignancy, considering the clinical history, a 
thorough search for melanin pigment was made; and rare pigmented malignant cells, as 
well as, a few melanophages were detected, confirming the diagnosis of metastatic 
melanoma in both the sites. 
3.5 Interpretation of melanotic melanoma and its differentiation from other pigmented 
lesions 
Often a cytopathologist needs to be cautious, when interpreting melanotic melanoma as 
well. Appearance of melanin pigment in cytologic smears varies according the stain used. 
Most cytology laboratories use one of the Romanowsky stains (in our laboratory it is May-
Grünwald- Giemsa) along with the Papanicolou (PAP) and haematoxylin-eosin (H-E) stains. 
Various authors describe melanin pigment to be yellow to brown-black, and bluish-black in 
the Papanicolaou/  H-E stained, and dark-brown to black on the May-Grünwald-Giemsa 
(MGG) stained smears (Saqi et al., 2002; Kashyap et al., 2002). In our experience, melanin 
pigment takes up shades of brown colour with the Papanicolaou (figure 10), and bottle-
green hue with MGG stain (figure 7). The intensity of color varies with the amount of intra 
or extracellular melanin pigment. An abundant pigment obscures the cytomorphologic 
details, necessitating the need for a careful search for cells with preserved morphology 
(figure 7). Owing to the overlapping shades of color, the melanin pigment needs to be 
differentiated from other endogenous pigments such as lipofuscin, hemosiderin and bile; 
special stains such as Perl’s, periodic-acid-Schiff (PAS), Fontana-Masson and Ziehl-Neelsen 
(Z-N) stains are useful in this regard (Perry et al., 1986). Melanin is positive with Fontana-
Masson; lipofuscin with PAS and Z-N stains; and hemosiderin with Perl’s stain. Bile 
pigment is generally identified by its greenish-black and yellowish-green appearance in 
MGG and Papanicolaou stains respectively (Orell, 1999). Gathering appropriate history is 
also of relevance in differentiating melanin pigment from that of tattooing. Tattooing 
(intradermal injection of an exogenous pigment) is known to cause discoloration of the 
draining lymph nodes resulting in so called ‘tattoo lymphadenitis‘ (Bordea et al., 2009). 
Anthracotic pigment, the other exogenous pigment, generally does not cause diagnostic 
difficulty, as it is confined to the alveolar macrophages of the respiratory cytologic samples;   
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Fig. 7. FNA smear from inguinal node showing an abundant bottle-greenish pigment 
obscuring the cell morphology (MGG stain, x400) 
 
 
Fig. 8. Aspirate from the intra-abdominal mass of the same case showing pleomorphic 
melanoma cells with a rare cell displaying melanin pigment (MGG stain, x400) 
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Fig. 9. Another microscopic field from the abdominal aspirate showing dissociated, 
pleomorphic, non-pigmented melanoma cells 
 
 
Fig. 10. Abundant melanin pigment with shades of browinish color (PAP stain, X400) 
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their absence in epithelial/  epithelial-like cells is of help in excluding a melanoma, or, other 
pigmented neoplasms. Although, the pigment can also be seen in an anthracotic node, it is 
rarely sampled for cytologic examination. There has been a case report of exaggerated 
pigmented granulomatous reaction to the artificial joint implant in a 72-year-old man who 
had undergone bilateral total hip arthroplasty, in whom, aspirate from the inguinal region 
was misinterpreted as metastatic melanoma from an unknown primary. Microscopically, the 
smears of this patient showed both intracellular and extracellular black pigment with 
obscured cytomorphology; although, appreciable cells were reported to be pleomorphic 
with prominent nucleoli. The patient had no evidence of primary cutaneous melanoma. On 
surgical exploration and histologic examination, what was presumed to be the bulky 
enlarged lymph nodes was found to be the soft tissue with pigment-laden macrophages and 
granulomatous reaction that occurred as a response to metallic prosthetic material. This rare 
case further emphasizes the need for critical attention to the clinical details and also a careful 
cytologic evaluation in the presence of pigmented debris obscuring the cytomorphology 
(Xin et al., 2004). Table 3 shows various types of pigments and their distinguishing features.  
 
Pigment  History, location and 
microscopic 
appearance 
Fontana-
Masson 
Perl’s stain PAS stain Z-N stain  
Melanin  Shades of brown on 
Papanicolau & bottle 
greenish-blackish on 
MGG stains 
Positive  Negative Negative Negative 
Hemosiderin  Golden-brown on 
Papanicolaou & 
greenish-
brown/ blackish on 
MGG 
Negative  Positive Negative Negative 
Lipofuscin Golden-yellow to 
brown, 
autofluorescence 
Negative Negative Positive Positive 
Blie  Cytologic samples 
from liver, greenish 
black with MGG and 
yellowish green with 
PAP stain 
Negative Negative Negative Negative 
Carbon 
(anthracotic)  
Alveolar 
macrophages in the 
respiratory samples 
Negative Negative Negative Negative 
Tattoo  History of tattooing Negative Negative Negative Negative 
Table 3. Showing features distinguishing various pigments 
In the context of the pigmented lesions, we would like to share our experience of a 
pigmented pulmonary neoplasm in which we suggested the possibility of pulmonary 
melanoma. Unfortunately, due to the patient’s refusal to undergo further FNAC /  biopsy, 
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work-up of this case was incomplete; however, based on the available clinical data and a 
careful cytomorphologic evaluation of the intra-thoracic FNA material from the lung, we 
could suggest a diagnosis of ‘primary pulmonary melanoma’. A solitary lung lesion in the 
absence of swelling or lesion elsewhere (skin, GIT and eye); and a predominant population 
of dissociated or loosely clustered cells (figs 11 & 12), made us consider the possibility of a 
primary pulmonary melanoma, rather than the metastatic deposit. Here, the point noteworthy 
is that a pigmented neoplasm in the intra-thoracic location need not necessarily be a melanoma 
and should be differentiated from other rare pigmented tumors like melanocytic carcinoid, 
melanotic paraganglioma and melanotic schwannoma (Dountsis et al., 2003). Morphologically 
our case did not fit into any of these lesions. To our knowledge, melanocytic carcinoid and 
melanotic paraganglioma have not been documented on cytology, but there have been rare 
case reports of melanotic schwannoma diagnosed on FNAC, as well as on exfoliative 
cytology. In all these cases the authors found it highly difficult to distinguish melanoma vs. 
schwannoma, not only due to the morphologic overlap, but also due to its 
immunophenotypic and ultrastructural resemblance (Jaffer et al., 2000; Schmitz et al., 2005). 
Melanotic schwannoma most frequently occurs in the paraspinal region and less commonly 
at locations such as the intestines, heart, bronchus, liver, skin, soft tissue and bone (Jaffer et 
al., 2000). The table 4 shows the differential diagnosis of an intra-thoracic melanotic lesion. 
 
Pigmented 
lesion 
Number/location Evidence of 
extra-primary 
site  
Cytology  
Primary 
melanoma  
Usually 
solitary/ lung  
Nil  High cell yield; dispersed/  loosely 
clustered, pleomorphic malignant cells; 
inclusion-like nucleoli; intra-nuclear 
cytoplasmic inclusions  
Metstatic 
melanoma 
Usually 
multiple/  lung
Detectable on 
further work-
up: eg. Skin, 
GIT or eye  
Same as that of primary melanoma 
Melanocytic 
carcinoid 
Usually 
solitary/  lung 
Nil   Depends on the type of carcinoid (classic, 
atypical, spindle cell  or, adenocarcinoid)  
Melanotic 
schwannoma  
Usually solitary/  mediastinal Usually, a spindle cell population with 
other features such as Verocay bodies 
Melanotic 
paraganglioma 
Usually solitary/  mediastinal Evidence of cells with red cytoplasmic 
granularity 
Table 4. Differential diagnosis of an intra-thoracic melanotic lesion on FNAC 
Melanoma of lung is extremely rare accounting for 0.01% of all lung tumors. Clinically, it is 
confused with other conventional types of lung cancer (Wilson et al., 1997). The tumor is 
frequently endobronchial in origin and 30% of the cases are diagnosed incidentally on chest 
radiography (Ost et al., 1999). A preoperative computed tomography guided FNAC is of 
great help in its detection; this was how it was detected in our patient as well. The proposed 
criteria for diagnosing the primary pulmonary melanoma comprise clinical detection of a 
solitary lung tumor; absence of melanoma of the skin, mucous membrane and eye or, any 
other detectable tumor at the time of diagnosis; histologically demonstrable junctional 
changes like “dropping off”  or “nesting”  of melanoma cells just beneath the bronchial  
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Fig. 11. The aspirate smear from primary pulmonary melanoma showing a microscopic field 
with a predominant spindle cell population (PAP stain, X400) 
 
 
Fig. 12. Another microscopic field from the same case showing loosely cohesive pigmented 
melanoma cells with epithelioid morphology; Inset A- a pigmented neoplastic cell (MGG 
stain, X400); Inset B- a melanophage (MGG stain, X400) 
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epithelium; and invasion of the bronchial epithelium by melanoma cells. Although, more 
than 30 cases of the primary pulmonary melanomas are documented, not all of them have 
met the required criteria. Due to the small number of cases reported, experience with respect 
to the management and the prognosis of the disease is also limited (Dountsis et al., 2003). 
However, the surgical treatment includes resection of the tumor with an oncologically 
adequate margin; lobectomy, or pneumonectomy (Rosai, 2001). As for the occurrence of 
pulmonary melanoma, one of the hypotheses says that melanocytes exist throughout the 
body as cells of a dispersed neuroendocrine system. Normally, these melanocytes migrate to 
the epidermis and the dermoepidermal junction of the skin, but they may also migrate to the 
viscera during embryogenesis. This hypothesis suggested for locations like esophagus and 
larynx may also be applicable for lung (Pomeranz et al., 1995). 
The other melanotic lesions to be considered by the cytopathologists are dermatopathic 
lymphadenopathy, pigmented basal cell carcinoma (BCC) and Bednar tumor. Dermatopathic 
lymphadenopathy is easily differentiated from metastatic melanoma not only by the clinical 
history, but also by the distinct cytomorphologic features. Smears from a case of 
dermatopathic lymphadenitis show a spectrum of reactive lymphoid cells along with 
cohesive (usually) clusters of melanin-laden histiocytes, in contrast to characteristically 
discohesive melanoma cells. We have documented a case of pigmented BCC which 
displayed basaloid, as well as, spindle cell population seen as cohesive fragments, and 
clusters on cytologic smears. Cytologically, the absence of cell-dissociation easily excluded a 
melanoma, while a combination of basaloid and spindle cells excluded a Bednar tumor. 
Cohesive clusters of basaloid cells at places exhibiting peripheral palisading favored a 
definitive diagnosis of pigmented BCC. (Siddaraju et al., 2008) 
The incidence of melanoma in India is low as compared to that of the western population 
(Nair et al., 1998). Most cases of melanoma we encounter in our institute (JIPMER, which is a 
referral center) are those involving the soles of the feet. Many of these patents are males who 
present with inguinal lymphadenopathy. In the last two years, we encountered 27 metastatic 
melanomas, most of them with primaries in the soles of the feet. The morphologic aspects we 
recorded were similar to those already described in the indexed literature. Personally, I have 
not come across the variants such as pure balloon cell, myxoid and signet ring cell melanomas. 
In our experience, diagnosing pigmented melanoma is not much of a problem (although, care 
needs to be taken with the pigmented lesions as well); but diagnostic difficulties are common 
with amelanotic melanomas and the problem should be resolved with an extreme attention to 
the clinical details, as well as, by the application of ancillary tests. In my personal experience, 
the cytomorphologic features of great assistance in the accurate cytodiagnosis of amelanotic 
melanoma are a high cell-yield; dispersed, pleomorphic cell population; inclusion-like 
prominent nucleoli and the presence of intranuclear cytoplasmic inclusions.  
3.6 Ancillary tests for melanoma 
Immunocytochemistry is the most useful ancillary test in difficult situations. Specific 
immunomarkers for melanoma include HMB-45, Melan-A, tyrosinase and microphthalmia 
transcription factor. S-100, although least specific, is of great practical importance, as it is 
more consistently positive in melanoma than any other specific markers. Also, the entities 
that enter the differential diagnosis of melanoma are generally negative for S-100. 
Melanoma antigen recognized by T cells (MART-1) is another sensitive as well as specific 
marker for melanoma. Between melan A and MART-1, Melan A has a tendency to stain 
more cells (Fetsch et al., 2001). Not just the melanoma markers, but also a panel of markers 
need to be used depending on the differential diagnosis. Thus, one may have to use various 
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epithelial (such as cytokeratin), mesenchymal (such as vimentin) and hematolymphoid  
(B and T, as well as CD68) markers depending on the clinical and cytomorphologic 
manifestations (Pelayes et al., 2010). Some authors have shown liquid-based cytology (LBC) 
preparations to be superior to conventional smears for ICC (Pelayes et al., 2010). Very rarely 
ultrastructural features need to be evaluated for diagnosing melanomas and the features 
include the presence of premelanosomes and melanosomes. Melanoma of soft parts or Clear 
cell sarcoma of soft parts (CCSSP) is phenotypically and immunohistochemically 
indistinguishable from cutaneous melanoma. Although, clinical features and certain 
cytomorphologic findings are of some value in distinguishing between the two, a definitive 
diagnosis may require the cytogenetic evaluation. This may be of particular importance with 
metastatic/  recurrent lesions with inadequate history (Tong et al., 2002; Kumar et al., 2003; 
Salem Shabb et al., 2003). 
3.7 Role of cytology in ocular melanomas  
Clinical diagnosis of ocular melanoma is difficult, especially, when the lesion is amelanotic. 
Ocular cytology, in particular FNAC can assist in its accurate diagnosis, especially with the 
ancillary aids (Kashyap et al., 2002; Augsburger et al., 2002; Char et al., 2006; Young et al., 
2007 & 2008; Solo et al., 2009). FNAC, when done with essential precaution under the 
supervision of an ophthalmologist and under CT/  US guidance, provides highly accurate 
results (Solo et al., 2009). Studies have found no evidence of local tumor dissemination or 
recurrence following FNA (Faulkner-Jones et al., 2005; Pelayes et al., 2010). Young et al. in 
their study of 25 patients with macular choroidal melanoma, could obtain diagnostic 
material in 74% of the cases. Although, complications such as retinal perforation, 
submacular/  vitreous hemorrhage occurred in some cases, none of them required treatment. 
Submacular and vitreous hemorrhages cleared spontaneously within a month’s period 
(Young et al., 2008). Augsburger et al. (2002) reported their experience of transvitreal FNAC 
of 34 small, non-invasive, melanocytic choroidal tumors. The cell-yield was diagnostic in 
64.7% the cases. Of these, 47.1% were diagnosed as melanoma and the rest were interpreted 
as intermediate lesions (11.8%) and benign nevi (5.9%) respectively. The cases with 
insufficient FNA material (12 lesions) were designated as "nevus versus melanoma" for 
facilitating a further FNA follow-up. Four of these "nevus versus melanoma" cases were 
eventually reclassified as small choroidal melanomas and treated; while the others turned 
out to be benign nevi. Thus, considerable numbers of small melanocytic choroidal tumors 
that were likely to be categorized as ‘choroidal melanoma’ were shown to be benign nevi or 
intermediate lesions on FNA follow-up (Augsburger et al., 2002). 
Iris ring melanomas are rare. In the initial stage, either they are not diagnosed or 
misdiagnosed as ‘pigmentary glaucoma’. The patients with iris ring melanomas may not 
have an obvious mass lesion and, present usually with a subtle heterochromia or marked 
pigmentation, visible only in the trabecular meshwork. Most series have described an iris 
ring melanoma as a tumor involving the 360 degrees of the anterior chamber angle, 
although it can sometimes present as an apparently focal iris mass. Char et al. (2006) could 
accurately diagnose 11 of 16 cases (69%) on FNAC, performed using a 25 gauge needle 
going through a transcorneal route into the iris - corneal angle 180 degrees away from the 
main tumour mass. In cases of heterochromia without a distinct mass, an area of angle 
pigmentation was aspirated in the same manner. Morphologically, most cases were either 
of spindle cell, or, mixed spindle/  epithelioid morphology. The limitation of FNAB in 
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diagnosing iris ring melanomas is that, even in an optimal setting, the specimens are 
paucicellular, often leaving the cytopathologists in a diagnostic dilemma (Char et al., 
2006).  
Cytology has a significant role in distinguishing pigmented lesions of the conjunctiva which 
can be benign, pre-malignant, or frankly malignant (melanoma). Conjunctival melanomas 
are potentially lethal and they arise in association with pre-existing primary acquired 
melanosis (PAM). It is important to recognise and monitor this precursor lesion owing to its 
malignant potential. Follow-up of suspicious conjunctival lesions by repeated biopsies may 
cause symblepharon, lid deformities, and discomfort to the patient. Conjunctival impression 
cytology using cellulose acetate paper has been in use for diagnosing various ocular surface 
disorders. Being less distressing to the patients, this quick, simple, non-invasive and 
inexpensive technique has proven useful for neoplastic lesions as well. The technique 
involves pressing a 2 x 6 mm cellulose acetate filter paper (millipore) held by forceps onto 
the conjunctival surface with the aid of a small solid rod for 3 to 5 seconds. The cellulose 
acetate imprint strip (obtained without using topical anaesthesia) is placed in a fixative 
containing glacial acetic acid, 37% formaldehyde, absolute ethyl alcohol and distilled water. 
Subsequently, the specimen is stained with PAS/  Papanicolaou stains and mounted on glass 
slides.  
The topographic distribution and relative proportion of atypical melanocytes are better 
appreciated on impression cytology. Benign conditions such as conjunctival nevus and 
primary acquired melanosis (PAM) without atypia are not associated with the ascent of 
atypical melanocytes through the conjunctival epithelium; while the late stages of PAM and 
obvious melanomas are associated with the ascent. This is the basis for the interpretation of 
conjunctival impression cytology (Paridaens., 1992). Paridaens et al. (1992) evaluated 
conjunctival imprint cytology in differentiating melanocytic tumours of the bulbar 
conjunctiva in 24 patients. Impression cytology predicted the histologic diagnosis by 
detection of superficial atypical melanocytes and their proportion relative to benign epithelial 
cells in 73% of the cases (Paridaens et al., 1992). One should remember that the benign nevi, 
PAM without atypia, and early stages of PAM with atypia can only be diagnosed by 
histology, with cytology being ‘negative’ in such instances. Repeated examinations may 
increase the sensitivity of impression cytology. A disadvantage of touch imprint cytology, in 
comparison to exfoliative cytology, is the difficulty in focusing due to the thickness of the 
filter paper, which affects the cytologic assessment. Another limitation is its inability to 
sample the lesions located in the fornix and tarsal conjunctiva; in these cases, one can opt for 
exfoliative cytology with the use of cotton wool swab after topical anaesthesia. In general, 
although a diagnostic biopsy remains necessary for determination of the origin and extent of 
the lesions; the use of imprint cytology can minimise the frequency of biopsy in recurrent 
tumors and suspicious areas (Paridaens et al., 1992). 
Our experience with ocular melanomas is limited. In one of our studies that evaluated the 
use of fine needle cytology in orbital and eyelid lesions, we had a single case of recurrent 
choroidal melanoma, which was diagnosed with the non-aspiration needling technique. 
Although grossly, material obtained appeared scanty, presence of obvious malignant cells 
with melanin pigment facilitated an easy diagnosis (Solo et al., 2009). 
3.8 Melanoma of soft parts 
“Melanoma of the soft parts (MSP)”  or “clear cell sarcoma of the soft parts (CCSSP)”  is a 
distinct entity with unique genetic rearrangement (t12;22) (q13;q12). Its morphologic, 
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immunohistochemical and ultrastructural resemblance to cutaneous melanoma is well 
established. This phenotypic resemblance between the two necessitates the need for 
distinguishing CCSSP from the metastatic deposits of cutaneous melanoma (Kumar et al., 
2003). Morphologhic features shared by these tumors on FNA smears include high cell 
yield; a predominant population of dissociated cells with plasmacytoid, polygonal and 
rarely spindle shapes; hyperchromasia (in some cases); prominent, round nucleoli and 
intranuclear cytoplasmic inclusions (INCIs). Mitoses are rare or variable and intracellular 
melanin is extremely rare (Tong et al., 2002; Kumar et al., 2003; Salem Shabb et al., 2003). 
Features such as 3-D clusters with microacinar pattern (Tong et al., 2002; Kumar et al., 2003); 
pale, blue, fragile or vacuolated and clear cytoplasm; a few bi- and multinucleated cells, 
vesicular nuclei (Tong et al., 2002; Kumar et al., 2003); extreme pleomorphism with bizarre 
giant cells and frequent mitoses have also been described in CCSSP (Tong et al., 2002; 
Kumar et al., 2003; Salem Shabb et al., 2003). As in melanoma, tumor cells exhibit positivity 
with histochemIcal stains such as Fontana-Masson and Schmorl’s stains (Tong et al., 2002; 
Kumar et al., 2003) and immunohistochemically express melanoma markers such as S-100, 
HMB-45 and melan-A (Tong et al., 2002; Kumar et al., 2003). Ultrastructurally, often they 
show melanocytic differentiation with melanosomes (Tong et al., 2002; Kumar et al., 2003). 
However, clinically, the tumor differs from cutaneous melanoma by its younger age group 
(median age 30), female predilection and a general tendency to involve the tendons and 
fascia of the upper and lower extremities. Prognostically, in comparison to cutaneous 
melanoma, it runs an indolent course, although bigger tumors are likely to show a rapid 
deterioration (Tong et al., 2002) with multiple local recurrences, distant metastasis and 
poorer prognosis (Kumar et al.2003). Owing to the considerable morphologic overlap, a 
variety of cytologic differential diagnoses are considered, of which the important ones 
comprise alveolar soft part sarcoma, carcinomas, synovial sarcoma and epithelioid sarcoma 
(Kumar et al., 2003). Chong et al. (1997) documented a case of CCSSP of the gluteal region in 
a 12-year-old child, manifesting as a small round cell sarcoma on FNAC. The case exhibited 
cohesive cell balls, rossettes and dissociated cells in a clean background. Many cells had 
eccentric nuclei with irregularly dispersed chromatin, occasional intranuclear vacuoles and 
eosinophilic nucleoli; the later features in an aspirate from the deep seated mass, in a child 
should suggest the possibility of CCSSP and prompt an ICC demonstration of melanoma 
markers (Chong et al., 1997). 
3.9 Further advances in cytology of melanoma 
In situations where routine cytomorphology and immunomarkers fail to contribute to the 
diagnosis of melanoma, certain other ancillary studies on cytologic samples (some of which 
are molecular-based) have shown to provide useful diagnostic and prognostic information. 
Angeletti et al (2004) performed a novel tyramide-based tyrosinase assay (a simple in-situ 
biochemical test) on FNA material obtained from a small series of melanoma patients. For 
standardization, the authors used YUGEN8 melanoma cell lines and the HeLa cells as 
positive and negative controls respectively. They showed this simple, quick and inexpensive 
assay to be a sensitive and specific method for diagnosing melanoma on cytologic samples. 
At molecular level, HSP-70 protein, C-myc oncogene, and HLA-DR antigen are said to play 
a significant role in the metastasis and prognosis of cutaneous melanomas. Kalogeraki et al. 
(2006) studied immunoexpression of these proteins on cytologic material by ICC, and found 
it to be significantly associated with ‘Clark levels’. In particular, HSP-70 expression is 
believed to be of value in the identification of melanoma patients with poor prognosis 
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(Kalogeraki et al., 2006). Studies also have shown tyrosinase reverse transcription 
polymerase chain reaction (RT-PCR) on fine-needle aspirates (FNA-PCR) to increase the 
diagnostic sensitivity of cytology, when US/  FNAC fails to detect the sentinel node 
metastasis in melanoma (Voit et al., 1999). Such studies have been performed on exfoliative 
samples as well. In a study involving 79 urine samples from patients with metastatic 
melanoma, Savoia et al. (2008) demonstrated that RT-PCR studies on exfoliative samples 
increased the sensitivity of cytology. The authors emphasized its utility as an additional tool 
in cases of negative or suspicious conventional urinary cytology. 
Also being performed is the cytogenetic analysis on FNA material for detection of monosomy 
3, an abnormality, associated with the adverse outcome in patients with uveal melanomas. 
Young et al. (2008) successfully carried out fluorescent-in-situ-hybridization (FISH) and/  or 
GeneChip 500k NspI Mapping array analysis on cytologic samples from 24 patients with 
macular choroidal melanoma and based on their results, emphasized its importance in the 
detection of chromosomal aberrations on cytologic material. However, Maat et al. (2007) 
demonstrated the heterogeneity for copy of chromosome 3 on FISH analysis performed on 
paraffin sections and felt that assigning patients to risk categories based on FNA samples for 
cytogenetic studies (for monosomy3) may be subject to error. Another significant study on 
FNA material by McCannel et al. (2010) demonstrated 2 cytogenetically distinct groups of 
choroidal melanomas characterized by chromosome 3 loss, or chromosome 6p gain. These 
findings may provide new insight into the biologic nature of choroidal melanoma and are 
likely to contribute to the development of targeted therapies (McCannel et al., 2010). 
4. Conclusion  
A variety of cytologic techniques are available to aid clinical evaluation of patients with 
melanoma, of which fine needle aspiration cytology (FNAC) is the frontrunner. The 
techniques have a significant role, particularly in the detection of potential metastatic sites 
and the recurrent lesions. They have a major role in the pre-therapeutic diagnosis of primary 
ocular melanomas and their recurrence. Though, specifically not indicated, it is often useful 
for incidental detection of primary cutaneous melanomas and also, the primary melanomas 
occurring elsewhere. With adequate and appropriate clinical details, an experienced 
cytopathologist, acquainted with the varied cytomorphologic spectrum, in particular of 
amelanotic melanomas can provide a reasonable diagnosis in most cases. The use of ancillary 
aids such as immunocytochemistry (ICC) and electron microscopy (EM) are of critical value 
in the diagnostically challenging cases. The care also needs to be taken when interpreting 
the pigmented lesions, to exclude the rare lesions simulating melanotic melanomas. Currently, 
the ultrasound (US) examination of sentinel node with fine needle aspiration cytology 
(FNAC) is under consideration as a potential, cost-effective alternative to sentinel lymph 
node biopsy (SLNB). Also, being attempted is the use of cytologic material for the molecular 
and cytogenetic evaluation to provide useful prognostic information with the possible 
therapeutic implication. Clinicians should make judicious use of the simple, non-invasive/  
minimally invasive cytologic techniques in the management of melanoma patients. 
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